FDA Inspection 1122259 — Reproductive Medicine Institute
The FDA completed an inspection of Reproductive Medicine Institute on February 5, 2020 in Bloomingdale, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 5, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bloomingdale, IL (United States)